Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Environ Manage ; 318: 115545, 2022 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-35752006

RESUMO

Research has proven the adaptation of nitrite-oxidizing bacteria to unfavorable environmental conditions, and this work presents a novel concept to prevent nitrite oxidation during partial nitrification in wastewater. The approach is based on the real-time updating of mathematical models of the process to search for optimal set-points of pH and oxygen concentration in a continuous activated sludge reactor with a high sludge age (20.3 days). A heuristic optimization technique by 13 optimum set-points simultaneously maximized the degree of ammonia oxidation (α) and nitrite accumulation (ß), achieving an (α + ß) = 190% per day. The activated sludge reactor was conducted for 780 days under three control schemes: open-loop control, fuzzy model supervisory control and phenomenological supervisory control. The phenomenological supervisory control system achieved the best results, simultaneously reaching 95% ammonium oxidation and 90% nitrite accumulation. The Haldane kinetics were analyzed using steady-state concentrations of all nitrogen species, concluding that the simultaneous maximization of α + ß led to selecting set-points at the extreme values of the following ranges: pH = 7.5-8.5 and DO = 0.8-1.0 mg O2/L, which enabled the inhibition of one nitrifier species. At the same time, the other one was relieved from inhibition. The 16sRNA assays indicated that the nitrite-oxidizing bacteria presence (genera Nitrobacter and Nitrospira) shifted from 32% to less than 8% after 280 days of continuous operation with optimal pH and oxygen set-points.


Assuntos
Nitritos , Esgotos , Bactérias , Reatores Biológicos/microbiologia , Concentração de Íons de Hidrogênio , Nitrificação , Oxirredução , Oxigênio , Esgotos/microbiologia
2.
Exp Eye Res ; 158: 51-58, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27450911

RESUMO

Steroid-induced IOP elevation affects a significant number of patients. It results from a decrease in outflow facility of the aqueous humor. To understand the pathophysiology of this condition a number of model systems have been created. These include ex-vivo cell and organ cultures as well as in-vivo animal models in organisms ranging from rodents to primates. These model systems can be used to investigate specific aspects of steroid-induced IOP elevation. This brief review summarizes the strengths and limitations of the various model systems and provides examples of where these systems have been successfully used to advance our understanding of steroid-induced IOP elevation.


Assuntos
Modelos Animais de Doenças , Glucocorticoides/efeitos adversos , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/induzido quimicamente , Malha Trabecular/efeitos dos fármacos , Animais , Técnicas de Cultura de Células , Dexametasona/efeitos adversos , Glaucoma/induzido quimicamente , Glaucoma/fisiopatologia , Humanos , Hipertensão Ocular/fisiopatologia , Técnicas de Cultura de Órgãos , Malha Trabecular/patologia , Triancinolona Acetonida/efeitos adversos
3.
Exp Eye Res ; 128: 114-6, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25304217

RESUMO

We have previously shown that tissue plasminogen activator (tPA) injected in the vitreous of sheep, reduced or prevented the elevation of the intraocular pressure (IOP) normally produced by the instillation of 1% prednisolone. We now report the effect of tPA when injected into the anterior chamber (AC) in amounts of 0.01, 0.001 and 0.0001 µg diluted in a volume of 50 µL. Lyophilized tPA, obtained as Actilyse 50 mg from Boehringer Ingelheim containing arginine was utilized. The Actilyse was diluted in balanced salt solution to obtain the desired amount of tPA in 50 µL. An identical solution containing only arginine was prepared to inject into the contralateral eye as a control. Six sheep of the Corriedale breed were selected. At the beginning of the study all eyes received instillation of 1% prednisolone 3 times/day for 10 days to elevate their IOP from 10 mm Hg to about 23 mm Hg. Then, 0.0001 µg was injected into one of the eyes and its effect was followed for up to 55:00 h while the instillation of prednisolone continued in both eyes. The same protocol was implemented for the 0.001 and 0.01 µg amounts after extended washout and IOP was over 22 mm Hg. The injection of 0.0001 µg into the AC had no effect on an IOP of 23.0 mm Hg at 6:00 and 30:00 h after injection. 0.001 µg of tPA reduced IOP from 23.1 to 18.6 mm Hg at 6:00 h but IOP recovered to 22.3 mm Hg at 30:00 h. Injection of 0.01 µg produced a marked and prolonged reduction of IOP. From a baseline of 23.0, IOP was reduced to 14.0, 14.7, 21.2, and 20.9 mm Hg at 5.0, 23.0, 27.0 and 45.5 h, respectively. The 0.423 µg of arginine, which is associated with 0.01 µg tPA, was injected alone and had no effect. Recombinant human tPA injected in the AC is effective in reversing steroid-induced IOP elevation in sheep. The reduction of IOP elevation may be the result of an effect on extra-cellular matrix turnover in the TM. These findings suggest that tPA may by useful as a therapeutic agent in steroid-induced glaucomas.


Assuntos
Câmara Anterior/efeitos dos fármacos , Glucocorticoides/toxicidade , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/tratamento farmacológico , Prednisolona/toxicidade , Ativador de Plasminogênio Tecidual/farmacologia , Animais , Modelos Animais de Doenças , Hipertensão Ocular/induzido quimicamente , Ovinos
4.
Invest Ophthalmol Vis Sci ; 54(13): 7903-9, 2013 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-24176900

RESUMO

PURPOSE: To investigate whether tissue plasminogen activator (tPA) can prevent and/or reverse steroid-induced IOP elevation in an ovine model. METHODS: Three animal groups were subjected to bilateral steroid-induced IOP elevation using thrice daily topical ocular prednisolone administration. In the first group (N = 8), one eye each of two sheep was injected intravitreally with 100 µg, 200 µg, 500 µg, or 1 mg human recombinant tPA, while contralateral eyes received vehicle. In the second group (N = 2), one eye was injected intravitreally with tPA (100 µg), while contralateral eyes received vehicle containing L-arginine. In the third group (N = 4), each animal received intravitreal tPA in one eye concurrently with initiation of bilateral steroid administration. IOP was monitored for the duration of the experiment. Tissues from eyes of the third group were used to determine relative gene expression. RESULTS: In the first and second groups, IOP decreased by 9.7 (±2.8) and 9.7 (±1.6) mm Hg, respectively, 24 hours after tPA administration. In the third group, tPA-treated eyes did not develop IOP elevation with ΔIOP of 11.8 (±1.3) mm Hg 8 days later. In all tPA-treated eyes, IOP remained low until the end of the study. mRNA levels in the trabecular meshwork were decreased for plasminogen activator tissue (PLAT), increased for matrix-metalloproteinase 1 (MMP-1), and stable for plasminogen activator inhibitor 1 (PAI-1), MMP-2, MMP-9, and MMP-13 in tPA-treated eyes compared with contralateral controls. PAI-1 mRNA levels in ciliary processes also remained similar. CONCLUSIONS: Recombinant human tPA is effective in both preventing and reversing steroid-induced IOP elevation in sheep. Tissue plasminogen activator may be useful as a therapeutic agent in steroid-induced glaucoma.


Assuntos
Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/tratamento farmacológico , Ativador de Plasminogênio Tecidual/administração & dosagem , Animais , Modelos Animais de Doenças , Progressão da Doença , Relação Dose-Resposta a Droga , Feminino , Fibrinolíticos/administração & dosagem , Regulação da Expressão Gênica , Injeções Intravítreas , Metaloproteinases da Matriz/biossíntese , Metaloproteinases da Matriz/genética , Hipertensão Ocular/induzido quimicamente , Hipertensão Ocular/fisiopatologia , Prednisolona/toxicidade , RNA/genética , Reação em Cadeia da Polimerase em Tempo Real , Ovinos , Malha Trabecular/enzimologia
5.
Exp Eye Res ; 111: 67-70, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23562660

RESUMO

Sildenafil citrate increases ocular blood flow and accelerates the rate of anterior chamber refilling after paracentesis. The latter effect could have resulted from a reduction in outflow facility or from an increase in aqueous humor (AH) production. In this study, we used scanning ocular fluorophotometry to examine the effects of sildenafil on AH turnover, and thus, AH production in eyes of live normal rabbits. For this, the rate of aqueous humor flow (AHF) was quantified with a commercially available fluorophotometer that measured the rate of fluorescein clearance from the anterior segment, which predominantly occurs via the trabecular meshwork. After ≈2 h of control scans to determine the baseline rate of AHF, the rabbits were fed 33 mg of sildenafil and allowed ≈45 min for the drug to enter the systemic circulation. Thereafter, fluorescence scans were retaken for an additional 90-120 min. Sildenafil ingestion increased AHF by about 36%, from 2.31 µL/min to 3.14 µL/min (P < 0.001, as two-tailed paired data, n = 20 eyes). This observation indicates that sildenafil citrate, which is a phosphodiesterase type-5 inhibitor currently marketed as a vasodilator (e.g., Viagra, Revatio), stimulates AHF in rabbits. Our results seem consistent with reports indicating that the drug dilates intraocular arteries and augments intraocular vascular flow. These physiological responses to the agent apparently led to increased fluid entry into the anterior chamber. As such, the drug might have utility in patients with ocular hypotony resulting from insufficient AH formation.


Assuntos
Humor Aquoso/efeitos dos fármacos , Humor Aquoso/metabolismo , Inibidores da Fosfodiesterase 5/farmacologia , Piperazinas/farmacologia , Sulfonas/farmacologia , Animais , Câmara Anterior/irrigação sanguínea , Câmara Anterior/metabolismo , Corpo Ciliar/irrigação sanguínea , Corpo Ciliar/metabolismo , Fluorofotometria , Purinas/farmacologia , Coelhos , Fluxo Sanguíneo Regional/efeitos dos fármacos , Citrato de Sildenafila
6.
Invest Ophthalmol Vis Sci ; 53(11): 7087-96, 2012 Oct 11.
Artigo em Inglês | MEDLINE | ID: mdl-22969071

RESUMO

PURPOSE: In 1997, a theoretical model was developed that predicted the existence of an internal, Na(+)-driven fluid circulation from the poles to the equator of the lens. In the present work, we demonstrate with a novel system that fluid movement can be measured across the polar and equatorial surface areas of isolated cow lenses. We have also determined the effects of ouabain and reduced bath [Na(+)]. METHODS: Lenses were isolated in a chamber with three compartments separated by two thin O-rings. Each compartment, anterior (A), equatorial (E), and posterior (P), was connected to a vertical capillary graduated in 0.25 µL. Capillary levels were read every 15 minutes. The protocols consisted of 2 hours in either open circuit or short circuit. The effects of ouabain and low-Na(+) solutions were determined under open circuit. RESULTS: In 21 experiments, the E capillary increased at a mean rate of 0.060 µL/min while the A and P levels decreased at rates of 0.044 and 0.037 µL/min, respectively, closely accounting for the increase in E. The first-hour flows under short circuit were approximately 40% larger than those in open-circuit conditions. The first-hour flows were always larger than those during the second hour. Preincubation of lenses with either ouabain or low-[Na(+)] solutions resulted in reduced rates of fluid transport. When KCl was used to replace NaCl, a transitory stimulation of fluid transport occurred. CONCLUSIONS: These experiments support that a fluid circulation consistent with the 1997 model is physiologically active.


Assuntos
Líquidos Corporais/metabolismo , Cristalino/fisiologia , Equilíbrio Hidroeletrolítico/fisiologia , Animais , Capilares/fisiologia , Permeabilidade Capilar/efeitos dos fármacos , Bovinos , Cultura em Câmaras de Difusão , Eletrônica/métodos , Inibidores Enzimáticos/farmacologia , Desenho de Equipamento , Pressão Hidrostática , Técnicas In Vitro , Modelos Biológicos , Ouabaína/farmacologia , Potássio/farmacocinética , Sódio/farmacocinética , Cloreto de Sódio/farmacocinética , Equilíbrio Hidroeletrolítico/efeitos dos fármacos
7.
Invest Ophthalmol Vis Sci ; 53(2): 565-73, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22205610

RESUMO

PURPOSE: Sildenafil increases ocular blood flow. Thus, the authors investigated if it also increases anterior chamber (AC) refilling after paracentesis. METHODS: Corriedale sheep and albino rabbits were used as animal models. Intraocular pressure (IOP) was measured, paracentesis performed on one eye, and AC refilling followed by observation using oblique illumination. IOP measurements continued as the AC formed. After IOP stabilization, sildenafil (100 mg) was orally administered. Forty to 60 minutes later, AH was withdrawn from the contralateral eye. The point at which IOP recovered was used to determine refilling time. Paracentesis volumes were either 60, 120, or 300 µL in sheep, and 50 or 100 µL in rabbits. RESULTS: IOP recovered in approximately 49, 56, and 50 minutes after the 60, 120, and 300 µL withdrawals in sheep. The refilling times of the contralateral eye after sildenafil ingestion were approximately 19, 26, and 37 minutes for the respective AH withdrawals. With rabbits, IOP recovered in approximately 13 minutes after the 50 and 100 µL AH withdrawals. After sildenafil, the IOP recovery times of the fellow eye were approximately 6 minutes. AH refilling rates were estimated by dividing the paracentesis volume by IOP recovery time. After sildenafil, such rates were larger than the AH formation rate attributed to secretion by the ciliary epithelium. CONCLUSIONS: Sildenafil accelerates the rate of AC refilling and might have beneficial utility as an agent enhancing fluid entry into the AC of patients who experienced AH loss during eye surgery, as well as in some cases of ocular hypotony.


Assuntos
Câmara Anterior/fisiopatologia , Humor Aquoso/metabolismo , Pressão Intraocular/efeitos dos fármacos , Hipotensão Ocular/tratamento farmacológico , Paracentese , Piperazinas/farmacologia , Recuperação de Função Fisiológica/efeitos dos fármacos , Sulfonas/farmacologia , Animais , Câmara Anterior/cirurgia , Modelos Animais de Doenças , Feminino , Masculino , Hipotensão Ocular/metabolismo , Hipotensão Ocular/fisiopatologia , Purinas/farmacologia , Coelhos , Fluxo Sanguíneo Regional/efeitos dos fármacos , Ovinos , Citrato de Sildenafila , Tonometria Ocular , Vasodilatadores/farmacologia
8.
Exp Eye Res ; 93(6): 798-803, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21970901

RESUMO

Based on our previous work showing that cow and rabbit lenses isolated with their accommodation anatomical components intact change volume during simulated accommodation in vitro, and that hyposmolality and hyperosmolality also produce volume changes, we tested the idea that exerting these forces simultaneously may add or counteract each other. Further, we attempted to find a point at which osmotic and mechanical forces may cancel each other. Using previously described methodology, we found that combined stretching and anisotonic conditions applied to a lens always produced less of a volume change than that observed on its paired lens from the fellow eye that was only subjected to anisotonic conditions. Our results suggest that a stretching force that increases the equatorial diameter by 0.4% and reduces the lens volume by 1.8% could be canceled by a hyposmotic force of about -20 to -30 mOsM. Counter-intuitively, lenses that were subjected to stretching and hyperosmolality had less volume decrease than their paired lenses only exposed to hypertonicity. This latter observation is likely due to the prevention by the mechanical stretching forces of the shortening of the equatorial diameter, which normally occurs in hypertonic media.


Assuntos
Cristalino/fisiologia , Mecanotransdução Celular , Acomodação Ocular , Animais , Feminino , Soluções Hipertônicas , Soluções Hipotônicas , Técnicas In Vitro , Cristalino/anatomia & histologia , Tamanho do Órgão , Pressão Osmótica , Coelhos , Estresse Mecânico
9.
Invest Ophthalmol Vis Sci ; 52(12): 8636-45, 2011 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-21980000

RESUMO

PURPOSE: To determine whether gene expression changes occur in the trabecular meshwork (TM) of cow eyes with steroid-induced intraocular pressure (IOP) elevation. METHODS: Adult female Braford cows (n = 4) were subjected to uniocular prednisolone acetate treatment for 6 weeks. IOP was monitored with an applanation tonometer. At the conclusion of the experiment, animals were euthanized, eyes were enucleated, and the TM was dissected and stored in an aqueous nontoxic tissue storage reagent. RNA was extracted and subjected to microarray analysis using commercial oligonucleotide bovine arrays. Some of the genes differentially expressed between control and experimental eyes were confirmed by quantitative RT-PCR and some of the respective proteins were studied by immunoblotting. RESULTS: IOP began to increase after 3 weeks of treatment, reaching a peak 2 weeks later. IOP differences between corticosteroid-treated and fellow control eyes were 6 ± 1 mm Hg (mean ± SD) at the conclusion of the study. Microarray analysis revealed that expression of 258 genes was upregulated, whereas expression of 187 genes was downregulated in the TM of eyes with steroid-induced IOP elevation. Genes identified to be differentially expressed include genes coding for cytoskeletal proteins, enzymes, growth and transcription factors, as well as extracellular matrix proteins and immune response proteins. A number of relevant gene networks were detected by bioinformatic analysis. CONCLUSIONS: Steroid-induced IOP elevation alters gene expression in the bovine TM. Identification of genes with changing expression in this model of open-angle glaucoma may help elucidate the primary changes occurring at the molecular level in this condition.


Assuntos
Glaucoma de Ângulo Aberto/induzido quimicamente , Glaucoma de Ângulo Aberto/genética , Hipertensão Ocular/induzido quimicamente , Hipertensão Ocular/genética , Prednisolona/análogos & derivados , Malha Trabecular/fisiologia , Animais , Anti-Inflamatórios/farmacologia , Bovinos , Biologia Computacional , Modelos Animais de Doenças , Feminino , Expressão Gênica/efeitos dos fármacos , Expressão Gênica/fisiologia , Glaucoma de Ângulo Aberto/fisiopatologia , Pressão Intraocular/efeitos dos fármacos , Pressão Intraocular/fisiologia , Modelos Genéticos , Hipertensão Ocular/fisiopatologia , Análise de Sequência com Séries de Oligonucleotídeos , Prednisolona/farmacologia , Reação em Cadeia da Polimerase em Tempo Real
10.
Med Hypotheses ; 77(5): 827-31, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21855227

RESUMO

Few studies have characterized how pressure in the anterior chamber (AC) of the eye is transmitted via the vitreous to the vitreous-ganglion cell interface. We are aware of only one study that simultaneously measured the pressures in the AC and vitreous humor; and of only one study that simultaneously measured the pressures in the AC and the suprachoroidal space (SCS). The pressure in the AC is defined as the intraocular pressure (IOP), which when elevated beyond statistically normal limits is a recognized risk factor for glaucoma, a malady best described as an optic neuropathy with degeneration and eventual death of the retinal ganglion cells (GC's) and highly characteristic changes in the optic nerve head (ONH). Most investigators currently believe that the prevalent risk factor for GC apoptosis is ocular hypertension, but no one has demonstrated how an increase in IOP in the AC is transmitted to the GC's. In patients with primary open angle glaucoma, the pressure in the AC increases due to an increase in the resistance of the trabecular meshwork (TM) outflow pathway. We questioned how such increased pressure in the AC would be transmitted to the GC to produce the changes in the ONH seen in glaucoma. Based on our preliminary data and purview of the literature, we hypothesize that a pressure increase originating in the AC is likely transmitted via both the SCS and the vitreous, with transmission via the former pathway probably most efficient in affecting the GC. Independently of the mechanism that produces GC apoptosis, the ones that are first affected, as repeatedly shown by visual field tests, are the most peripheral ones; i.e., those whose axons are the most external as they form the ONH and enter the lamina cribrosa. There are no published reports explaining this peculiarity. The dogma is that the pressure transmitted via the vitreous is higher at the periphery because it is transmitted across a shorter distance, since the vitreous acts as a buffer that absorbs part of the pressure being transmitted. We propose that IOP is not only transmitted via the vitreous but also via the SCS. Increases in IOP could be efficiently applied via the SCS to the most external axons of the ONH as they leave the eye. Our hypothesis can also explain low-tension glaucoma in which the most peripheral GC's are also affected first, because pressure is transmitted without decay due to a reduced uveoscleral (UVS) flow.


Assuntos
Câmara Anterior , Pressão Intraocular , Nervo Óptico , Humanos , Modelos Teóricos
11.
Exp Eye Res ; 93(1): 103-7, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21651908

RESUMO

Anecdotal reports have suggested that the vasodilator, sildenafil citrate, which evokes its effect via a select inhibition of PDE5, has the potential to increase intraocular pressure (IOP) in some individuals. An ocular hypertensive effect by sildenafil was also recently described in a sheep animal model. In contrast, clinical studies have not found a direct association between sildenafil ingestion (commonly consumed as Viagra) and changes in IOP. However, some such studies also reported no effects of sildenafil on systemic blood pressure (BP) at the time of the IOP determination. Given this surprising result, our purpose was to repeat a study in human volunteers in the city of Corrientes, Argentina to corroborate the effects of sildenafil on human IOP and systemic BP. For the present study, 9 healthy volunteers (male and female, 18-74 years old) were selected as subjects after ophthalmic and cardiovascular evaluation indicated that they exhibited normal parameters for their age. In a masked, placebo-controlled study, the subjects ingested 100 mg sildenafil citrate (provided as Vorst from Laboratorios Bernabo, Argentina) in one session, and a placebo on a second separate occasion. IOP was measured with a Goldman applanation tonometer by an ophthalmologist, and BP by a second physician, neither of whom witnessed the tablet ingestion by the volunteers, nor provided with information on the nature of the test compounds. A third individual administered the tablets. The average baseline IOP of this group of 9 was 13.1 ± 0.6 mm Hg. Subsequent to sildenafil ingestion, IOP increased by 26% to 16.5 ± 0.8 mm Hg 60 min later (P < 0.005, as paired data), and returned to control values within 2 h. Both systolic and diastolic BP were significantly reduced by sildenafil ingestion. At the point of maximal systemic hypotension (90 min), the systolic and diastolic pressures declined by 15% and 13%, respectively. No significant changes in IOP or BP were recorded after ingestion of the placebo. Our results suggest that sildenafil can elicit a transient IOP increase that may be of importance to patients chronically treated with PDE5 inhibitors for various vascular diseases (e.g., pulmonary hypertension). We discuss possible mechanisms by which PDE5 inhibition might lead to a rise in IOP.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Pressão Intraocular/efeitos dos fármacos , Inibidores da Fosfodiesterase 5/farmacologia , Piperazinas/farmacologia , Sulfonas/farmacologia , Vasodilatadores/farmacologia , Administração Oral , Adolescente , Adulto , Idoso , Humor Aquoso/metabolismo , Determinação da Pressão Arterial , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Purinas/farmacologia , Citrato de Sildenafila , Tonometria Ocular , Adulto Jovem
13.
Invest Ophthalmol Vis Sci ; 51(8): 4060-6, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20237246

RESUMO

PURPOSE: To analyze morphologic changes in the trabecular meshwork (TM) of bovine eyes treated with topical prednisolone and exhibiting elevated intraocular pressure for 4 weeks. METHODS: The TM of four adult Braford cow eyes treated with 0.5% prednisolone eye drops three times daily for 7 weeks and their contralateral eyes treated with artificial tear preparation and that of two adult untreated Braford cows and untreated young calves eyes were analyzed with light and electron microscopy. Increased extracellular matrix (ECM) under the outflow loops was evaluated quantitatively. Additionally, deparaffinized tissue of treated eyes was labeled with an antibody against type VI collagen for immunocytochemistry. RESULTS: In steroid-treated eyes ECM (plaques) accumulated under the endothelium of the inner wall of the outflow loops. On electron microscopy, this material contained fine fibrils that labeled for type VI collagen. Plaques were also seen in the contralateral controls of the treated animals but here they were significantly less in amount. In the untreated Braford controls and in untreated calf eyes, plaques were nearly absent. In the TM cells of the treated eyes there was a loss of glycogen from the cytoplasm and an increase in basement membrane-like material. These changes were not seen in contralateral eyes or eyes of untreated animals. CONCLUSIONS: Accumulations of ECM in the treated eyes resembled morphologic changes in human eyes with primary open-angle glaucoma and steroid-induced glaucoma. This animal model, therefore, provides a good tool in which to further study the pathogenesis of TM changes in glaucoma.


Assuntos
Glucocorticoides/farmacologia , Prednisolona/farmacologia , Malha Trabecular/efeitos dos fármacos , Administração Tópica , Animais , Bovinos , Colágeno Tipo VI/metabolismo , Matriz Extracelular/metabolismo , Feminino , Pressão Intraocular , Malha Trabecular/metabolismo
14.
Arch Ophthalmol ; 128(3): 338-43, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20212205

RESUMO

OBJECTIVE: To confirm the ocular hypotensive effects of anecortave acetate on an ovine model for steroid-induced ocular hypertension. Eyes of normal sheep exhibit a robust steroid-induced ocular hypertensive response. Recent observations in an uncontrolled, interventional case series indicated that anecortave elicited hypotensive effects when administered as a sub-Tenon depot in the eyes of a small sample of patients with glaucoma. METHODS: Intraocular pressure (IOP) was monitored by Perkins applanation tonometry in 16 normal sheep receiving topically administered prednisolone acetate, 0.5%, in both eyes, 3 times daily, a protocol that doubled IOP within 12 days. Half of the sheep had received a unilateral sub-Tenon injection of anecortave in 1 eye prior to the initiation of the bilateral prednisolone instillations, while the 8 remaining sheep received the unilateral anecortave sub-Tenon depot after the IOP was maximally elevated by the prednisolone instillations. RESULTS: In these 2 sets of experiments, the presence of the anecortave depot suppressed the steroid-induced IOP elevation and reverted the elevated IOP to baseline levels. Measurements of aqueous outflow facility indicated that eyes treated with prednisolone plus anecortave exhibited a 5.8-fold higher outflow facility than the fellow eyes solely exposed to prednisolone, indicating that anecortave prevented the increase in outflow resistance produced by the corticosteroid. CONCLUSION: Elucidation of the mechanisms of action of anecortave in animal models may prove relevant to the design of novel interventions for the management of primary open-angle glaucoma.


Assuntos
Inibidores da Angiogênese/administração & dosagem , Modelos Animais de Doenças , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/prevenção & controle , Pregnadienodiois/administração & dosagem , Administração Tópica , Animais , Humor Aquoso/metabolismo , Feminino , Glucocorticoides/toxicidade , Injeções , Hipertensão Ocular/induzido quimicamente , Prednisolona/análogos & derivados , Prednisolona/toxicidade , Ovinos , Tonometria Ocular
16.
Invest Ophthalmol Vis Sci ; 51(6): 3042-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20089869

RESUMO

PURPOSE: To investigate whether intracameral injection of the adenovirus vector AdhGRE.MMP1 would reduce or prevent elevated intraocular pressure (IOP) induced by corticosteroids in living animals. METHODS: Glucocorticoid-inducible adenovirus vectors carrying wild-type or mutant forms of human metalloproteinase 1 (MMP1 and mutMMP1) cDNAs were generated. An adenovirus carrying no gene (Ad5.CMV.Null) was used as an additional control. Sheep were injected intracamerally with 30 microL of each vector, either previously or after the induction of increased IOP with topical prednisolone or sub-Tenon triamcinolone under various protocols. IOP was measured with a Perkins tonometer. Inflammation was monitored by visual inspection. RESULTS: In eyes in which IOP was already elevated to 24 to 30 mm Hg, injection of AdhGRE.MMP1 reduced IOP by 70% in 24 hours and to 10 to 13 mm Hg in 48 hours. In eyes with normal IOP (9-11 mm Hg), preinjection of the virus protected against the increase in IOP normally produced by the corticosteroid. IOP remained at a level of approximately 12 mm Hg for 5 days despite the continuous application of the corticosteroid. Injections of the control viruses had no hypotensive effects. There were no signs of ocular inflammation or discomfort to the animals. CONCLUSIONS: A single dose of a gene therapy vector carrying an inducible metalloproteinase human gene can both protect against the IOP increase produced by corticosteroid instillation in the sheep model and quickly reverse the IOP increase previously elicited by the corticosteroid. These results are a first step toward a treatment of steroid-glaucoma with inducible overexpression of extracellular matrix modulator genes.


Assuntos
Adenoviridae/genética , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Terapia Genética , Glucocorticoides/toxicidade , Metaloproteinase 1 da Matriz/genética , Hipertensão Ocular/terapia , Animais , Câmara Anterior/virologia , Modelos Animais de Doenças , Feminino , Vetores Genéticos , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/induzido quimicamente , Prednisolona/toxicidade , Ovinos , Tonometria Ocular , Triancinolona Acetonida/toxicidade
17.
Invest Ophthalmol Vis Sci ; 51(6): 3139-44, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20089876

RESUMO

PURPOSE: To determine the effects of vasodilators on intraocular pressure (IOP) and the protein content of sheep aqueous humor (AH), because the vasodilators may increase fluid leakage from the fenestrated capillaries of the ciliary body to the extracellular tissue and directly to the anterior chamber (AC) via the iris, and some senior patients (older than 70) treated with sildenafil have exhibited elevated IOP. METHODS: Experiments were performed on domestic sheep residing on a ranch in Argentina. These docile and compliant animals readily swallowed tablets of sildenafil (50 and 100 mg) and tadalafil (20 mg). IOP was monitored by Perkins applanation tonometry in 21 normal sheep receiving orally administered drugs. In addition, paracentesis was performed on six sheep to quantify changes in AH protein levels. RESULTS: Ingestion of both sildenafil and tadalafil increased sheep IOP from normal levels of approximately 9 to 11 mm Hg within 1 hour. The IOP elevation was approximately 1.6-fold with both doses of sildenafil. IOP returned to control values within 4 hours. With the longer-lasting vasodilator tadalafil, IOP remained 1.6- to 1.9-fold higher than normal for at least 48 hours and returned to control levels within 4 days. The AH protein content was approximately 39% higher in sheep given 100 mg sildenafil. CONCLUSIONS: These data are consistent with a vasodilator-evoked increase in plasma-like fluid in the AC, which likely accounts for the IOP elevation. The results are discussed with a model for AH dynamics that may be of importance to senior individuals treated for vascular diseases with these compounds.


Assuntos
Humor Aquoso/metabolismo , Carbolinas/administração & dosagem , Pressão Intraocular/efeitos dos fármacos , Piperazinas/administração & dosagem , Sulfonas/administração & dosagem , Vasodilatadores/administração & dosagem , Administração Oral , Animais , Feminino , Masculino , Purinas/administração & dosagem , Ovinos , Citrato de Sildenafila , Tadalafila , Tonometria Ocular
18.
Environ Entomol ; 39(4): 1276-82, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22127178

RESUMO

The raspberry weevil, Aegorhinus superciliosus (Guérin) (Coleoptera: Curculionidae), is the most important pest in blueberry and raspberry fields in the south of Chile. In this study, we investigated the electroantennographic and behavioral responses of A. superciliosus to semiochemicals released from conspecific individual adults, with particular attention to male attraction to females. Odors released from females significantly attracted males in a Y-tube olfactometer. Gas chromatographic and mass spectral analysis of female volatile extracts revealed the presence of limonene and α-pinene. Electroantennogram recordings from both sexes indicated that males of A. superciliosus possess olfactory sensitivity for the R isomer of limonene and α-pinene, whereas females only perceived R-limonene. Behavioral assays using synthetic compounds showed that only R-limonene elicited an attraction response from male weevils. Field experiments confirmed the laboratory results, showing that R-limonene was attractive to weevils. This is the first report of intraspecific chemical communication in this weevil. We discuss the origin of these compounds, their possible role in the sexual behavior of this species, and their potential use in a pest control strategy.


Assuntos
Antenas de Artrópodes/fisiologia , Atrativos Sexuais/isolamento & purificação , Comportamento Sexual Animal , Gorgulhos/fisiologia , Animais , Feminino , Masculino , Odorantes , Compostos Orgânicos Voláteis/química , Gorgulhos/química
19.
Exp Eye Res ; 89(4): 469-78, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19427852

RESUMO

In vivo, mammalian lenses have the capacity to effect fully reversible changes in shape, and possibly volume, during the accommodation process. Isolated lenses also change shape by readily swelling or shrinking when placed in anisotonic media. However, the manner by which the lens changes its shape when its volume is changed osmotically is not firmly established. Putatively, the lens could swell or shrink evenly in all directions, or manifest distinctive swelling and/or shrinking patterns when exposed to anisotonic media. The present study measured physical changes in lenses consistent with the latter alternative using methods we developed for determining rapid changes in lens shape and volume. It was found in isolated rabbit and cow lenses that the length of the axis between the anterior and posterior poles (A-P length) primarily increases under hypotonic conditions (-40 to -100 mOsM), with smaller, or no changes, in equatorial diameter (ED). Hypertonic conditions (+50 to +100 mOsM) on rabbit lenses elicited a predominant reduction in ED, while the A-P length was only marginally reduced. Hypertonic solutions of +150 mOsM were required to obtain similar changes in cow lens shape. The ratio of the A-P length to the ED was taken as a measure of "circularity". This ratio increased gradually in rabbit and cow lenses bathed in hypotonic solutions because of the increase in the A-P length. The calculated lens volume increased in tandem with the increase in "circularity". Lens circularity also increased under hypertonic conditions due to the decrease in ED, but this increase in circularity during shrinkage was not as pronounced as that which occurred during swelling. As such, the lens has a tendency upon swelling to change its shape by approaching the structure of a globular spheroid (as occurs during accommodation for near focusing), but lens shrinkage does not result in a flatter lens with a reduced A-P length as occurs during dis-accommodation for distance focusing. Moreover, osmotically evoked shape changes appear irreversible, in contrast to the mechanically elicited shape changes of accommodation.


Assuntos
Soluções Hipertônicas/farmacologia , Soluções Hipotônicas/farmacologia , Cristalino/anatomia & histologia , Cristalino/efeitos dos fármacos , Acomodação Ocular/fisiologia , Animais , Bovinos , Coelhos
20.
Invest Ophthalmol Vis Sci ; 50(2): 669-73, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18824726

RESUMO

PURPOSE: To determine whether the ovine eye develops elevation of intraocular pressure (IOP) in response to corticosteroid applied topically. METHODS: IOP was monitored by Perkins applanation tonometry in a group of 18 sheep receiving topically administered 0.5% prednisolone acetate in one eye (experimental), three times daily, for a period of 3 or four 4 weeks after the establishment of baseline IOP values. Perkins readings were converted to actual mm Hg using a calibration curve derived from in vivo manometric measurements. IOP was monitored for an additional 1 to 3 weeks after discontinuation of corticosteroid treatment. RESULTS: Baseline IOP in normal sheep was 10.6+/-1.4 mm Hg (mean +/- SD; n=36 eyes). The IOP of the experimental eyes began to increase after 1 week of prednisolone treatment in all sheep and reached a peak 1 week later (27.5 mm Hg experimental vs. 11.7 mm Hg fellow, control eye; P<0.001). After the discontinuation of corticosteroid instillation, the IOP of the treated eyes declined to the baseline values over the course of 1 to 3 weeks. CONCLUSIONS: Ovine eyes exhibit a robust steroid-induced ocular hypertensive response, with 100% occurrence in this trial. The mechanisms of steroid-induced glaucoma may be related to those involved in primary open-angle glaucoma and could provide insight into primary open-angle and clues to its treatment.


Assuntos
Modelos Animais de Doenças , Glucocorticoides/toxicidade , Pressão Intraocular/efeitos dos fármacos , Hipertensão Ocular/induzido quimicamente , Prednisolona/análogos & derivados , Administração Tópica , Animais , Prednisolona/toxicidade , Ovinos , Tonometria Ocular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...